Focus: GS-III Science and Technology, Prelims
Why in news?
Covid-19 vaccines being developed by UK’s Oxford-AstraZeneca and United States’s Moderna-NIAID are the top candidates India is looking at for possible acquisition discussions.
- India is at present waiting for trial data for the Russian candidate, which became the first coronavirus vaccine to be approved in the world.
- For now, India is looking at the Oxford-AstraZeneca vaccine, which is in co-production with Serum Institute of India for the Indian market, the Moderna vaccine, which has also entered phase 3 trails and nine other vaccine development programmes — including ones in Germany and Israel.
-Source: Hindustan Times